Hidden among the detail of Spanish drugmaker Almirall’s financial results on Monday was news about the leadership of the Barcelona-based company. 21 February 2023
Shares in Almirall looked set to close nearly 5% higher after Monday’s trading following the firm’s presentation of its 2022 financial results. 20 February 2023
More compelling evidence of the safety and efficacy of delgocitinib has lifted the likelihood that Danish dermatology specialist LEO Pharma will be able to secu 10 February 2023
Advanz Pharma has announced that it has entered into an exclusive agreement with Alvotech, a global biotech company specialising in the development and manufact 6 February 2023
US drugmaker Bristol Myers Squibb was trading 2% higher at lunchtime Thursday after presenting its fourth quarter and full year financial results. 2 February 2023
Californian biotech Jasper Therapeutics has announced that it will focus on the development of its lead product candidate, briquilimab, in chronic diseases and 11 January 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.